Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 2CNS 2Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

Granulocyte Colony-Stimulating Factor 3Etoposide 3tazemetostat 2Thiotepa 2Mesna 2Melphalan 2Ifosfamide 2Filgrastim 2Carboplatin 2Busulfan 2sargramostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Rifampin 1Radiotherapy, Intensity-Modulated 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Leukapheresis 1Itraconazole 1Immunologic Techniques 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × omburtamab I-131 × Other solid neoplasm × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡